Monocyte count / HDL cholesterol ratio: A new marker in diabetic retinopathy

Aim: Diabetic retinopathy (DRP) makes up a significant portion of visual impairments. DRP is divided into proliferative and non-proliferative forms. Monocytes contribute to inflammation, whereas HDL reinforces the reversal of inflammation through promoting anti-inflammatory pathways. The monocyte-to-HDL cholesterol ratio (MHR) is one of the indicators that have been included in recent inflammation studies. This study aims to investigate the diagnostic value of MHR and whether it can be utilized as an indicator of diabetic retinopathy.Materials and Methods: This study includes patients diagnosed at least 5 years ago with type II diabetes mellitus (DM) who are ≥ 18 years old and have an HbA1c value > 6.5. The control group is made up of patients aged ≥ 18 years that presented to the outpatient clinic for other ailments of the eye. The data were prospectively recorded through the hospital information system. The subjects were divided into 3 groups: proliferative retinopathy, non-proliferative retinopathy, and control. Results: The study included a total of 200 subjects: 70 patients with diabetic non-proliferative retinopathy, 87 patients with diabetic proliferative retinopathy, and 43 patients without retinopathy. There were 92 male (46%) and 108 female patients (54%). The mean age was 66.35 ± 11.3 years (19-96). In this prospective observational study, we found that the MHR values of experimental and control groups were significantly different (p = 0.046). The post hoc Tukey's honest significant difference (HSD) test revealed a statistically significant difference between the control and proliferative retinopathy groups (p = 0.040), but not the non-proliferative retinopathy group (p = 0.125).Conclusion: MHR has diagnostic potential for diabetic retinopathy, especially for the proliferative form.

PDF

___

1. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Harrison’s Principles of Internal Medicine. 16th edition. Braunwald: McGraw-Hill; 2005
2. International Diabetes Federation. Diabetes Atlas. 8th edition, 2017. http://www.idf.org/diabetesatlas
3. Bath PM, Butterworth RJ. Trombosit size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-61.
4. Bancroft AJ, Abel EW, Mclaren M, et al. Mean platelets volume is a useful parameter:a reproducible routine method using a modified coulter thrombocytometer. Trombosits 2000;11:379-87.
5. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of newonset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
6. Walsh SR. Cook EJ, Goulder F, et al. Neutrophil – lymphocyte ratio as a prognostic factor in colrectal cancer. J Surg Oncol 2005;91:181-4
7. Gordon T, Castelli WP, Hjortland MC et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 977;62:707-14
8. Kanbay M, Solak Y, Unal HU, et al. Monocyte count/ HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014;46:1619-25.
9. Cetin EH, Cetin MS, Canpolat U, et al. Monocyte/HDLcholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med 2015;9:967-77.
10. Perez-Matos MC, Morales-Alvarez MC, Mendivil CO. Lipids: a suitable therapeutic target in diabetic neuropathy. J Diabetes Res 2017:6943851:1–9. .
11. Kundi H, Kiziltunc E, Cetin M, et al. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz. 2016;41:523–9.
12. Cetin MS, Cetin EH, Kalender E, et al. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart Lung Circ. 2016;25:1077-86.
13. Karatas A, Turkmen E, Erdem E, et al. Monocyte to highdensity lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomark Med 2018;12:953-9.
14. Vural G, Gümüşyayla Ş, Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy. Medicine (Baltimore). 2018;97.
15. Pençe H, Aktaş H. The Relationship Between Monocyte / HDL Cholesterol Ratio and Cardiovascular Risk in People with Diabetic Neuropathy. OTSBD. 2019;4:526- 38.